/
/
Killing AML Cells with Magrolimab, a New Immunotherapy Option, with Dr. Joseph Jurcic

Event Description

IF YOU WOULD PREFER TO JOIN THE SHOW BY PHONE, PLEASE CALL (515) 602-9728

*you need to join by phone if you want to ask Dr. Jurcic your questions.

Immunotherapy is one of the most promising areas of cancer research. Drugs like checkpoint inhibitors, monoclonal and bispecific anitbodies, antibody drug conjugates and CAR-T cell therapy are all extensively being studied in AML. 

Join us live on May 26th at 11 AM EST to learn from Dr. Joseph Jurcic, an AML expert from the Herbert Irving Comprehensive Cancer Center at Columbia University, about an exciting new immunotherapy drug in development called magrolimab which is a monoclonal antibody against CD47 and macrophage checkpoint inhibitor. 

During the show, Dr. Jurcic will discuss what magrolimab is, how it is helping AML patients and two upcoming trials he will be participating in that will use magrolimab in combination with other AML drugs. Learn all about the immune system and this emerging therapy with a unique opportunity to directly ask Dr. Jurcic your questions! 

Schedule & Agenda

11:00AM - 12:00PM
11:00AM
Kerith Amen
Welcome
Welcome, announcements and introduction
11:05AM
Dr. Joseph Jurcic
Interview
Dr. Jurcic will discuss what magrolimab is, how it is helping AML patients and two upcoming trials he will be participating in that will use magrolimab in combination with other AML drugs.
11:50AM
Audience
Questions and Answers
Audience is able to call in to the radio show (515) 602-9728 to ask Dr. Jurcic questions about what was discussed during our interview today.

Speakers & Moderators

The author Joseph Jurcic, MD
Joseph Jurcic, MD
New York, NY

Attending Physician in the Deparment of Medicine at New York-Presbyterian/Columbia University Medical Center, Professor of Medicine at Columbia University Irving Medical Center and Director of the Hematologic Malignancies Section in the Division of Hematology/Oncology.

The author Kerith Amen
Kerith Amen
New Orleans, Louisiana

Kerith joined HealthTree Foundation as a Community Co-Director for AML in 2022. She is a mother to a spirited eight-year-old daughter, Adair, and their beloved rescue, Violet. She lost her best friend and husband, Rob, to AML in March 2018. Kerith wishes she had a resource such as HealthTree for AML during Rob’s illness. She is a strong supporter of HealthTree's mission. She hopes that by sharing her experience, she may help other patients and caregivers navigate an AML diagnosis.

Have Any Questions?

Thank you for your interest in the event. If you have any question, we would love to help! Just fill out the form below and we will get back to you as quickly as possible.

support

Get In Touch With Us

phone

(800) 930-5159

email

Support@healthtree.org

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals
AbbVie
Genentech
Amgen

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811